title: The management of acne vulgaris in pregnancy.
abstract: Acne vulgaris is a common condition in adolescence and also for many women of childbearing age. The management of acne in pregnancy is complicated by the lack of clinical studies and pharmacokinetic data in this patient population and safety concerns regarding retinoid use in pregnancy. Of primary concern to both patients and clinicians is the safety profile of medications used during pregnancy. This review seeks to clarify what management options are available to treat acne during pregnancy and what data are available to guide decision making. Topical treatments are considered the safest option during pregnancy. They have the best safety profile and minimize the levels of systemic absorption, and therefore the least risk of fetal exposure. If these are applied properly with a strong emphasis on adherence, excellent results can be achieved.
authors.affiliation: Department of Dermatology, Aberdeen Royal Infirmary, Foresterhill, Aberdeen, AB25 2ZN, UK.
authors.forename: Fiona M
authors.initials: FM
authors.lastname: Meredith
authors.forename: Anthony D
authors.initials: AD
authors.lastname: Ormerod
mesh_terms: D000152:Acne Vulgaris / Q000188:drug therapy* / Q000628:therapy; D000279:Administration, Cutaneous; D000284:Administration, Oral; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001585:Benzoyl Peroxide / Q000627:therapeutic use; D005260:Female; D006801:Humans; D053685:Laser Therapy; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy* / Q000628:therapy; D012176:Retinoids / Q000627:therapeutic use
chemical_list: D000305:Adrenal Cortex Hormones; D000900:Anti-Bacterial Agents; D012176:Retinoids; D001585:Benzoyl Peroxide